Tue, September 26, 2023

Silvan Tuerkcan Maintained (BNTC) at Buy with Increased Target to $6 on, Sep 26th, 2023

Silvan Tuerkcan of JMP Securities, Maintained "Benitec Biopharma Inc." (BNTC) at Buy with Increased Target from $4 to $6 on, Sep 26th, 2023.

Silvan, nor any peers, have made any analyst calls on BNTC in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30